ANN ARBOR, Mich., Oct. 27 /PRNewswire/ -- MichBio, the association for Michigan's biosciences industry, today announced the names of the winning applicants for its Emerging Biosciences Showcase on Nov. 18, the first day of its statewide Expo. The purpose of the Showcase is to introduce venture capital firms from around the country to biosciences start-ups emerging in Michigan. The event provides selected companies with an opportunity to introduce their technologies to an audience of investors, technology experts, and other entrepreneurs.
The Expo is the largest annual gathering of biosciences professionals in the state and will be held Nov. 18-19 at the Rock Financial ShowPlace in Novi. This is the first time the Emerging Biosciences Showcase has been part of the Expo. The inaugural showcase was held last May in advance of the Michigan Growth Capital Symposium in Ann Arbor. Twelve companies presented at that event.
"We're excited to have the Emerging Biosciences Showcase as part of the Expo, which is a natural home for it," said Stephen Rapundalo, Ph.D., MichBio president and CEO. "We have expanded the format to allow a greater number of companies to introduce their new bioscience technologies and commercialization opportunities to the venture capital and angel investor community."
The program, which runs from 1-5:00 p.m., will begin with a keynote
address by Shelley B. Thunen, CFO of TherOx, Inc. in Irvine CA. Thunen has
held key management positions in a number of start-up companies, including
serving as CFO of IntraLase Corp. Following her comments, the program will
continue with nine-minute company presentations. Presenting companies
AI Medical Devices, Inc. - Medical devices emphasizing improved intubation
Armune BioScience, Inc. - High-value, protein signature-based
diagnostic/prognostic tests for certain cancers.
Aursos, Inc. - Drugs treatment for bone loss.
Copyright©2008 PR Newswire.
All rights reserved